Omipalisib

SI-5333

Omipalisib, >98% (HPLC)

CAS No. : [1086062-66-9]

MDL No. : MFCD16038929

Synonyms : GSK2126458; GSK458

IUPAC Name : 2,4-Difluoro-N-(2-methoxy-5-(4-(pyridazin-4-yl)quinolin-6-yl)pyridin-3-yl)benzenesulfonamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
500MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
1G	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Omipalisib is a potent and selective inhibitor of the PI3K/mammalian target of rapamycin (mTOR) pathway. Omipalisib has anti-cancer activity.

References : Knight S. D. et al.: ACS Med. Chem. Lett., 1 (1), 39-43, 2010; Greger J. G. et al.: Mol Cancer Ther., 11(4), 909-20, 2012; Kim H. G. et al.: ACS Chem Biol., 8(10), 2145-50, 2013.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.